loading

Protara Therapeutics Inc Stock (TARA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
7.34%
11.85
11.04 10.70 12.14 9.732
Operating Income/Loss
7.34%
-11.85
-11.04 -10.70 -12.14 -9.732
Nonoperating Income/Loss
7.80%
0.756
0.82 0.84 0.846 0.687
Income/Loss From Continuing Operations Before Tax
53.72%
-11.10
-23.97 -9.86 -11.29 -9.045
Income/Loss From Continuing Operations After Tax
8.55%
-11.10
-10.22 -9.86 -11.29 -9.045
Net Income/Loss
8.55%
-11.10
-10.22 -9.86 -11.29 -9.045
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.87K%
11.42
0.0113 11.35 11.31 11.30
Diluted Average Shares
100.87K%
11.42
0.0113 11.35 11.31 11.30
Basic Earnings Per Share
7.78%
-0.97
-0.90 -0.87 -1.00 -0.80
Diluted Earnings Per Share
7.78%
-0.97
-0.90 -0.87 -1.00 -0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):